O	0	10	Preventing
O	11	17	weight
O	18	22	gain
O	23	25	in
B-ethinicity	26	33	African
I-ethinicity	34	42	American
O	43	49	breast
O	50	56	cancer
O	57	66	survivors
O	67	72	using
B-intervention	73	78	smart
I-intervention	79	85	scales
I-intervention	86	89	and
I-intervention	90	98	activity
I-intervention	99	107	trackers
O	107	108	:
O	109	110	a
O	111	121	randomized
O	122	132	controlled
O	133	138	pilot
O	139	144	study
O	144	145	.

O	146	150	This
O	151	156	study
O	157	166	evaluated
O	167	170	the
O	171	182	feasibility
O	183	186	and
O	187	198	preliminary
O	199	207	efficacy
O	208	210	of
O	211	214	two
O	215	216	6
O	216	217	-
O	217	222	month
O	222	223	,
O	224	228	self
O	228	229	-
O	229	239	regulation
O	240	253	interventions
O	254	258	that
O	259	266	focused
O	267	269	on
O	270	275	daily
O	276	280	self
O	280	281	-
O	281	289	weighing
O	290	291	(
O	291	294	DSW
O	294	295	)
O	296	299	and
O	300	304	used
O	305	314	objective
O	315	325	monitoring
O	326	329	and
O	330	338	tailored
O	339	347	feedback
O	348	353	about
O	354	360	weight
O	361	362	(
O	362	363	±
O	363	371	activity
O	371	372	)
O	372	373	,
O	374	376	to
O	377	384	prevent
O	385	391	weight
O	392	396	gain
O	397	402	among
O	403	410	African
O	411	419	American
O	420	426	breast
O	427	433	cancer
O	434	443	survivors
O	443	444	.

O	445	457	Participants
O	458	459	(
O	459	460	n
O	461	462	=
B-total-participants	463	465	35
O	465	466	)
O	467	471	were
O	472	482	randomized
O	483	485	to
O	486	488	an
O	489	501	intervention
O	502	503	+
O	504	512	activity
O	513	523	monitoring
O	524	525	(
O	525	528	INT
O	528	529	+
O	529	530	)
O	530	531	,
O	532	544	intervention
O	545	546	(
O	546	549	INT
O	549	550	)
O	550	551	,
O	552	554	or
B-control	555	562	control
O	563	564	(
O	564	567	CON
O	567	568	)
O	569	574	group
O	574	575	.

O	576	589	Interventions
O	590	598	included
O	599	600	a
O	601	609	wireless
O	610	615	scale
O	616	617	(
O	617	618	±
O	618	626	activity
O	627	634	tracker
O	634	635	)
O	636	640	that
O	641	652	transmitted
O	653	662	objective
O	663	667	data
O	668	670	to
O	671	672	a
O	673	679	mobile
O	680	683	app
O	683	684	/
O	684	691	website
O	691	692	,
O	693	700	emailed
O	701	708	lessons
O	708	709	,
O	710	713	and
O	714	722	tailored
O	723	731	feedback
O	732	737	based
O	738	740	on
O	741	750	objective
O	751	757	weight
O	758	759	(
O	759	760	±
O	760	768	activity
O	769	773	data
O	773	774	)
O	774	775	.

O	776	788	Participants
O	789	798	completed
O	799	801	in
O	801	802	-
O	802	808	person
O	809	812	and
O	813	819	online
O	820	831	assessments
O	832	834	at
O	835	843	baseline
O	843	844	,
O	845	846	3
O	847	853	months
O	853	854	,
O	855	858	and
O	859	860	6
O	861	867	months
O	867	868	.

O	869	875	Ninety
O	875	876	-
O	876	880	four
O	881	888	percent
O	889	891	of
O	892	904	participants
O	905	914	completed
O	915	926	assessments
O	927	929	at
O	930	931	3
O	932	938	months
O	938	939	,
O	940	943	and
O	944	946	97
O	947	948	%
O	949	951	at
O	952	953	6
O	954	960	months
O	960	961	.

B-outcome	962	968	Median
I-outcome	969	970	(
I-outcome	970	973	IQR
I-outcome	973	974	)
I-outcome	975	981	weight
I-outcome	982	988	change
O	989	994	after
O	995	996	6
O	997	1003	months
O	1004	1007	was
B-iv-cont-median	1008	1009	-
I-iv-cont-median	1009	1010	0
I-iv-cont-median	1010	1011	.
I-iv-cont-median	1011	1012	9
I-iv-cont-median	1013	1014	%
O	1015	1016	(
O	1016	1017	-
O	1017	1018	4
O	1018	1019	.
O	1019	1020	4
O	1020	1021	-
O	1021	1022	0
O	1022	1023	.
O	1023	1024	1
O	1024	1025	)
O	1026	1028	in
O	1029	1032	the
O	1033	1036	INT
O	1036	1037	+
O	1038	1039	(
O	1039	1040	p
O	1041	1042	=
O	1043	1044	0
O	1044	1045	.
O	1045	1048	075
O	1048	1049	;
O	1050	1051	p
O	1052	1053	=
O	1054	1055	0
O	1055	1056	.
O	1056	1059	067
O	1060	1062	vs
O	1062	1063	.
O	1064	1067	CON
O	1067	1068	)
O	1069	1072	and
B-iv-cont-median	1073	1074	-
I-iv-cont-median	1074	1075	0
I-iv-cont-median	1075	1076	.
I-iv-cont-median	1076	1077	2
I-iv-cont-median	1078	1079	%
O	1080	1081	(
O	1081	1082	-
O	1082	1083	4
O	1083	1084	.
O	1084	1085	2
O	1085	1086	-
O	1086	1087	1
O	1087	1088	.
O	1088	1089	3
O	1089	1090	)
O	1091	1093	in
O	1094	1097	the
O	1098	1101	INT
O	1102	1108	groups
O	1109	1110	(
O	1110	1111	p
O	1112	1113	=
O	1114	1115	0
O	1115	1116	.
O	1116	1119	463
O	1119	1120	;
O	1121	1122	p
O	1123	1124	=
O	1125	1126	0
O	1126	1127	.
O	1127	1130	357
O	1131	1133	vs
O	1133	1134	.
O	1135	1138	CON
O	1138	1139	)
O	1139	1140	,
O	1141	1147	versus
O	1148	1149	a
B-cv-cont-median	1150	1151	0
I-cv-cont-median	1151	1152	.
I-cv-cont-median	1152	1153	2
I-cv-cont-median	1154	1155	%
O	1156	1157	(
O	1157	1158	-
O	1158	1159	0
O	1159	1160	.
O	1160	1161	7
O	1161	1162	-
O	1162	1163	1
O	1163	1164	.
O	1164	1165	7
O	1165	1166	)
O	1167	1171	gain
O	1172	1174	in
O	1175	1178	the
O	1179	1182	CON
O	1183	1188	group
O	1188	1189	.

O	1190	1193	The
O	1194	1204	proportion
O	1205	1207	of
O	1208	1211	INT
O	1211	1212	+
O	1212	1213	,
O	1214	1217	INT
O	1217	1218	,
O	1219	1222	and
O	1223	1226	CON
O	1227	1239	participants
O	1240	1244	that
O	1245	1249	were
O	1250	1252	at
O	1253	1255	or
B-outcome	1256	1261	below
I-outcome	1262	1270	baseline
I-outcome	1271	1277	weight
O	1278	1281	was
B-iv-bin-percent	1282	1284	72
I-iv-bin-percent	1284	1285	.
I-iv-bin-percent	1285	1286	7
O	1286	1287	,
B-iv-bin-percent	1288	1290	53
I-iv-bin-percent	1290	1291	.
I-iv-bin-percent	1291	1292	8
O	1292	1293	,
O	1294	1297	and
B-cv-bin-percent	1298	1300	45
I-cv-bin-percent	1300	1301	.
I-cv-bin-percent	1301	1302	5
I-cv-bin-percent	1303	1304	%
O	1304	1305	,
O	1306	1318	respectively
O	1319	1320	(
O	1320	1326	effect
O	1327	1332	sizes
O	1333	1334	d
O	1335	1336	=
O	1337	1338	0
O	1338	1339	.
O	1339	1341	64
O	1341	1342	,
O	1343	1344	d
O	1345	1346	=
O	1347	1348	0
O	1348	1349	.
O	1349	1351	18
O	1351	1352	)
O	1352	1353	.

O	1354	1358	Most
O	1359	1362	INT
O	1362	1363	+
O	1364	1376	participants
B-outcome	1377	1384	weighed
I-outcome	1385	1388	and
I-outcome	1389	1393	wore
I-outcome	1394	1402	trackers
I-outcome	1403	1404	≥
I-outcome	1404	1405	5
I-outcome	1406	1410	days
I-outcome	1410	1411	/
I-outcome	1411	1415	week
O	1416	1417	(
O	1417	1420	INT
O	1420	1421	+
O	1421	1422	,
B-iv-bin-percent	1423	1425	81
I-iv-bin-percent	1425	1426	.
I-iv-bin-percent	1426	1427	9
I-iv-bin-percent	1428	1429	%
O	1430	1432	vs
O	1432	1433	.
O	1434	1437	INT
O	1437	1438	,
B-iv-bin-percent	1439	1441	38
I-iv-bin-percent	1441	1442	.
I-iv-bin-percent	1442	1443	5
I-iv-bin-percent	1444	1445	%
O	1446	1448	vs
O	1448	1449	.
O	1450	1453	CON
O	1453	1454	,
B-cv-bin-percent	1455	1456	0
I-cv-bin-percent	1457	1458	%
O	1458	1459	;
O	1460	1461	p
O	1462	1463	<
O	1464	1465	0
O	1465	1466	.
O	1466	1470	0005
O	1470	1471	;
O	1472	1475	INT
O	1475	1476	+
O	1476	1477	,
O	1478	1480	72
O	1480	1481	.
O	1481	1482	7
O	1483	1484	%
O	1484	1485	)
O	1485	1486	.

O	1487	1491	Both
O	1492	1504	intervention
O	1505	1511	groups
B-outcome	1512	1521	perceived
I-outcome	1522	1525	DSW
I-outcome	1526	1528	as
I-outcome	1529	1537	positive
O	1537	1538	,
O	1539	1542	and
O	1543	1546	100
O	1547	1548	%
O	1549	1554	would
O	1555	1564	recommend
O	1565	1568	the
O	1569	1576	program
O	1577	1579	to
O	1580	1585	other
O	1586	1592	breast
O	1593	1599	cancer
O	1600	1609	survivors
O	1609	1610	.

O	1611	1613	An
O	1614	1626	intervention
O	1627	1634	focused
O	1635	1637	on
O	1638	1641	DSW
O	1642	1644	as
O	1645	1646	a
O	1647	1651	self
O	1651	1652	-
O	1652	1662	monitoring
O	1663	1671	strategy
O	1672	1677	shows
O	1678	1685	promise
O	1686	1689	for
O	1690	1700	preventing
O	1701	1707	weight
O	1708	1712	gain
O	1713	1715	in
O	1716	1722	breast
O	1723	1729	cancer
O	1730	1739	survivors
O	1739	1740	.

O	1741	1746	Daily
O	1747	1751	self
O	1751	1752	-
O	1752	1762	monitoring
O	1763	1765	of
O	1766	1772	weight
O	1773	1776	and
O	1777	1785	activity
O	1786	1789	may
O	1790	1792	be
O	1793	1794	a
O	1795	1803	feasible
O	1804	1807	and
O	1808	1818	accessible
O	1819	1827	approach
O	1828	1830	to
O	1831	1838	promote
O	1839	1845	weight
O	1846	1850	gain
O	1851	1861	prevention
O	1862	1864	in
O	1865	1871	breast
O	1872	1878	cancer
O	1879	1888	survivors
O	1888	1889	.

O	1890	1904	ClinicalTrials
O	1904	1905	.
O	1905	1908	gov
O	1908	1909	,
O	1910	1921	NCT02030353
O	1921	1922	.
